Showing results (41-50 of 472) with videos related to
Sort By:
Pageof 48
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 28, 2016
Mediterranean Diet and Hip Fracture in Swedish Men and WomenLiisa Byberg, Andrea Bellavia, Susanna C Larsson, et al.European Journal of Epidemiology|September 1, 2017
Sleep duration, mortality and the influence of ageTorbjörn Åkerstedt, Francesca Ghilotti, Alessandra Grotta, et al.Journal of Thrombosis and Thrombolysis|August 13, 2003
Quantitative comparison of coronary artery flow and myocardial perfusion in patients with acute myocardial infarction in the presence and absence of recent cocaine useJim Edward Weber, Judd E Hollander, Sabina A Murphy, et al.JAMA Cardiology|August 4, 2018
Efficacy and Safety of Further Lowering of Low-Density Lipoprotein Cholesterol in Patients Starting With Very Low Levels: A Meta-analysisMarc S Sabatine, Stephen D Wiviott, KyungAh Im, et al.Journal of Thrombosis and Thrombolysis|December 6, 2012
Urinary albumin concentration and long-term cardiovascular risk in acute coronary syndrome patients: a PROVE IT-TIMI 22 substudyBabak Nazer, Kausik K Ray, Sabina A Murphy, et al.American Heart Journal|April 29, 2008
High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients--a Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) analysisAmir Lotfi, Marc J Schweiger, Gregory R Giugliano, et al.Journal of the American College of Cardiology|August 1, 2006
Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapyChristopher P Cannon, Benjamin A Steinberg, Sabina A Murphy, et al.Journal of the American College of Cardiology|January 20, 2010
Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trialSabina A Murphy, Christopher P Cannon, Stephen D Wiviott, et al.Journal of Thrombosis and Thrombolysis|February 15, 2011
Impact of reduced glomerular filtration rate on outcomes in patients with ST-segment elevation myocardial infarction undergoing fibrinolysis: a CLARITY-TIMI 28 analysisShaheeda Ahmed, C Michael Gibson, Christopher P Cannon, et al.Circulation. Cardiovascular Quality and Outcomes|April 14, 2011
Benefit of intensive statin therapy in women: results from PROVE IT-TIMI 22Quynh A Truong, Sabina A Murphy, Carolyn H McCabe, et al.Pageof 48